Cargando…
Oncogenic KRAS alters splicing factor phosphorylation and alternative splicing in lung cancer
BACKGROUND: Alternative RNA splicing is widely dysregulated in cancers including lung adenocarcinoma, where aberrant splicing events are frequently caused by somatic splice site mutations or somatic mutations of splicing factor genes. However, the majority of mis-splicing in cancers is unexplained b...
Autores principales: | Lo, April, McSharry, Maria, Berger, Alice H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9756471/ https://www.ncbi.nlm.nih.gov/pubmed/36522653 http://dx.doi.org/10.1186/s12885-022-10311-1 |
Ejemplares similares
-
Phosphorylation-Mediated Regulation of Alternative Splicing in Cancer
por: Naro, Chiara, et al.
Publicado: (2013) -
Oncogenic splicing factor SRSF3 regulates ILF3 alternative splicing to promote cancer cell proliferation and transformation
por: Jia, Rong, et al.
Publicado: (2019) -
Disturbed Expression of Splicing Factors in Renal Cancer Affects Alternative Splicing of Apoptosis Regulators, Oncogenes, and Tumor Suppressors
por: Piekielko-Witkowska, Agnieszka, et al.
Publicado: (2010) -
Splicing is an alternate oncogenic pathway activation mechanism in glioma
por: Siddaway, Robert, et al.
Publicado: (2022) -
Alternative Splicing in Oncogenic Kinases: From Physiological Functions to Cancer
por: Druillennec, Sabine, et al.
Publicado: (2012)